State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?

被引:177
作者
Chmiel, JF [1 ]
Davis, PB [1 ]
机构
[1] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Dept Pediat, Cleveland, OH 44106 USA
关键词
D O I
10.1186/1465-9921-4-8
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Cystic Fibrosis (CF) lung disease, which is characterized by airway obstruction, chronic bacterial infection, and an excessive inflammatory response, is responsible for most of the morbidity and mortality. Early in life, CF patients become infected with a limited spectrum of bacteria, especially P. aeruginosa. New data now indicate that decreased depth of periciliary fluid and abnormal hydration of mucus, which impede mucociliary clearance, contribute to initial infection. Diminished production of the antibacterial molecule nitric oxide, increased bacterial binding sites (e.g., asialo GM-1) on CF airway epithelial cells, and adaptations made by the bacteria to the airway microenvironment, including the production of virulence factors and the ability to organize into a biofilm, contribute to susceptibility to initial bacterial infection. Once the patient is infected, an overzealous inflammatory response in the CF lung likely contributes to the host's inability to eradicate infection. In response to increased IL-8 and leukotriene B-4 production, neutrophils infiltrate the lung where they release mediators, such as elastase, that further inhibit host defenses, cripple opsonophagocytosis, impair mucociliary clearance, and damage airway wall architecture. The combination of these events favors the persistence of bacteria in the airway. Until a cure is discovered, further investigations into therapies that relieve obstruction, control infection, and attenuate inflammation offer the best hope of limiting damage to host tissues and prolonging survival.
引用
收藏
页数:12
相关论文
共 98 条
  • [91] Pulmonary inflammation induced by Pseudomonas aemginosa lipopolysaccharide, phospholipase C, and exotoxin A:: Role of interferon regulatory factor 1
    Wieland, CW
    Siegmund, B
    Senaldi, G
    Vasil, ML
    Dinarello, CA
    Fantuzzi, G
    [J]. INFECTION AND IMMUNITY, 2002, 70 (03) : 1352 - 1358
  • [92] ACUTE LUNG INJURY INDUCED BY PSEUDOMONAS-AERUGINOSA ELASTASE IN HAMSTERS
    WILLIAMS, JC
    LUCAS, BJ
    KNEE, C
    RENZETTI, M
    DONAHUE, J
    [J]. EXPERIMENTAL LUNG RESEARCH, 1992, 18 (01) : 155 - 171
  • [93] PYOCYANIN AND 1-HYDROXYPHENAZINE PRODUCED BY PSEUDOMONAS-AERUGINOSA INHIBIT THE BEATING OF HUMAN RESPIRATORY CILIA INVITRO
    WILSON, R
    PITT, T
    TAYLOR, G
    WATSON, D
    MACDERMOT, J
    SYKES, D
    ROBERTS, D
    COLE, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) : 221 - 229
  • [94] Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
    Wolter, J
    Seeney, S
    Bell, S
    Bowler, S
    Masel, P
    McCormack, J
    [J]. THORAX, 2002, 57 (03) : 212 - 216
  • [95] Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870
  • [96] WRETLIND B, 1983, REV INFECT DIS S, V5, P998
  • [97] X-ray microanalysis of airway surface liquid collected in cystic fibrosis mice
    Zahm, JM
    Baconnais, S
    Davidson, DJ
    Webb, S
    Dorin, J
    Bonnet, N
    Balossier, G
    Puchelle, E
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (02) : L309 - L313
  • [98] Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes
    Zughaier, SM
    Ryley, HC
    Jackson, SK
    [J]. INFECTION AND IMMUNITY, 1999, 67 (03) : 1505 - 1507